What Happened?
Austin, TX-based Genprex Appointed Hemant Kumar as Chief Manufacturing and Technology Officer
About the Company
Genprex (Nasdaq: GNPX) is a clinical-stage gene therapy company focused on developing life-changing technologies for patients with cancer and diabetes. Genprex`s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches for patients with cancer and other serious diseases.
About the Person
Hemant Kumar is Chief Manufacturing and Technology Officer at Genprex. Previously, Hemant held various senior IT leadership roles in the industry.
Info Source
News
Short Profile